Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06923501

Evaluation of a Mobile App Program for Coping With Cancer

The goal of this clinical trial is to learn if a mobile app program for people with a history of cancer can help treat distress. The main questions it aims to answer is:

Do participants use the Tools for Coping with Cancer Calm Health mobile app and do they find it helpful?

Does the Tools for Coping with Cancer Calm Health mobile app improve mood, quality of life, and help with coping?

Participants will be asked to use a 13-session self-management program (Tools for Coping with Cancer) housed within the Calm Health app. Participants will use this app on their own device, in their own home. Participants will have access to the program for 8 weeks and will be asked to work their way through the program at their own pace. Participants will be asked to complete questionnaires about their mood, quality of life, coping, and experience with the app three times: at the start of the study, after 8 weeks using the app, and then 3-months after using the app.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Smilow Cancer Hospital

New Haven, Connecticut, 06519, United States

Location status: Recruiting

Location contact

Gabriel Cartagena, PhD

CONTACT

[email protected]

516-855-8539

About this study

The purpose of this study is to evaluate the feasibility, acceptability, and preliminary effectiveness of a self-management mobile app on mood, quality of life, psychological flexibility, and adaptive coping in a population of people with cancer.

The intention of this research is to meet the most common unmet supportive care needs such as anxiety and depression, pain, insomnia, and fear of cancer recurrence utilizing evidence-based intervention that is accessible and self-paced.

We hypothesize that the Tools for Coping with Cancer mobile app program will:

  • Be feasible and acceptable to participants, as rated by interest, accrual, and completion rates, acceptability ratings, and participant satisfaction with the program.
  • Have a statistically significant effect on symptoms of depression, anxiety, psychological flexibility, adaptive coping, and quality of life. We further hypothesize that these improvements will be retained at 3-months post-intervention.

The primary objective is to determine the feasibility and acceptability of a self-management mobile app intervention as measured by participant interest, accrual, completion, satisfaction, acceptability, and app usage.

The secondary objective is to evaluate preliminary outcomes related to mood, quality of life, psychological flexibility, and adaptive coping, and will be measured using self-report questionnaires.

This is a prospective pilot feasibility, acceptability, and effectiveness study.

The intervention is a 13-session self-management program housed within the Calm Health app. Participants will have access to the program for 8 weeks and will be asked to work their way through the program at their own pace.

Participants will complete a series of self-report surveys to evaluate the primary and secondary objectives of the study. Additionally, researchers will have access to data reporting participant's usage patterns of the app, including the frequency and duration of session play.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stated willingness to comply with all study procedures and availability for the duration of the study (8 weeks active intervention and 3-month follow up)
  • Have a confirmed diagnosis of cancer; or have been treated for cancer within the last two years, including adjuvant therapies
  • Over the age of 18
  • Able to understand and read English
  • Able to navigate a mobile app with minimal assistance from study staff
  • Able to provide informed consent

Exclusion criteria

  • Are taking part in psychotherapy at any time during the study
  • Have an un-treated or under-treated mental health disorder based on pre-study screening that may require a referral to individual mental health care.

Treatment and study plan

Tools for Coping with Cancer Calm Health mobile app program

Device

Participants will be asked to use a 13-session self-management program "Tools for Coping with Cancer" within the Calm Health mobile app.

Primary outcomes

  1. Participant interest

    Time frame: Up to 12 months

    The number of individuals who initiate evaluating eligibility.

  2. Accrual

    Time frame: Up to 12 months

    The number of individuals who provide consent.

  3. Participant completion

    Time frame: Up to 12 months

    The number of individuals who complete all sessions of the program.

  4. Participant satisfaction

    Time frame: Up to 18 months

    A Likert-type scale ranging from very dissatisfied to very satisfied on the program overall as well as each session.

    Minimum value: 0 (not at all satisfied) Maximum value: 140 (Very satisfied with the program as a whole; very satisfied with each individual session) Lower numbers indicate worse outcome.

  5. Helpfulness

    Time frame: Up to 18 months

    A Likert-type scale ranging from very unhelpful to very unhelpful on the program overall as well as each session.

    Minimum value: 0 (not at all helpful) Maximum value: 140 (Found program as a whole and each individual session very helpful).

    Lower numbers indicate worse outcome.

  6. Acceptability

    Time frame: Up to 18 months

    A 10-item acceptability questionnaire (Theoretical Framework of Acceptability) evaluating affective attitude, burden, ethicality, perceived effectiveness, intervention coherence, self-efficacy, opportunity costs, and general acceptability.

    Minimum value: 0 Maximum value: 100 Higher score indicates greater acceptability

  7. Usage

    Time frame: Up to 18 months

    Participant usage of the app, including frequency and duration of session play will be captured.

Secondary outcomes

  1. Depression

    Time frame: Up to 18 months

    Will be measured using:

    Patient Health Questionnaire-8; a 8-item scale evaluating the frequency of depression symptoms over a two week period.

    Minimum score: 0 Maximum score: 24 Higher score = worse outcome

  2. Anxiety

    Time frame: Up to 18 months

    Will be measured using:

    Generalized Anxiety Disorder-7; a 7-item scale evaluating the frequency of anxiety symptoms over a two week period.

    Minimum score: 0 Maximum score: 21 Higher score = worse outcome

  3. Adaptive Coping

    Time frame: Up to 18 months

    Will be measured using the Brief COPE, a 28-item measure of coping in response to stressful situations.

    Minimum score: 28 Maximum score: 112 Outcome depends on the score of each subscale, of which there are 14. Some subscales reflect adaptive coping, while others reflective maladaptive coping.

  4. Health Related Quality of Life

    Time frame: Up to 18 months

    Will be measured by the FACT-G (Functional Assessment of Cancer Therapy, General), a 27-item questionnaire designed to measure four domains of health related quality of life in people with cancer: Physical, social, emotional, and functional well-being.

    Minimum score: 108 Maximum score: 0 Higher scores indicate better outcome

  5. Psychological Flexibility

    Time frame: Up to 18 months

    Will be measured by the Brief Experiential Avoidance Questionnaire, a 15-item questionnaire measuring willingness to remain in contact with distressing emotions, memories, thoughts, and physical sensations.

    Minimum score: 15 Maximum score: 90 Higher scores indicate worse outcomes

Study contacts

Contact information is provided by the study sponsor or research team.

Gabriel Cartagena, PhD

CONTACT

[email protected]

516-855-8539

Jennifer Kilkus, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Yale University

Other

Registry information

Official study title

Feasibility, Acceptability, and Preliminary Outcomes of a Mobile App for Coping With Cancer

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 11, 2025
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.